Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-043119
Filing Date
2021-06-24
Accepted
2021-06-24 18:16:09
Documents
1
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5419
  Complete submission text file 0001209191-21-043119.txt   7655
Mailing Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004
Business Address 350 106TH AVENUE NE, 1ST FLOOR BELLEVUE WA 98004 (425) 709-0772
Qiming U.S. Healthcare Fund II, L.P. (Reporting) CIK: 0001765710 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40523 | Film No.: 211044049

Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Issuer) CIK: 0001783032 (see all company filings)

EIN.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004
Business Address 11100 NE 8TH ST, SUITE 200 BELLEVUE WA 98004 425-709-0772
Qiming U.S. Healthcare GP II, LLC (Reporting) CIK: 0001868862 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40523 | Film No.: 211044048